Simon J Harrison

Simon J Harrison

UNVERIFIED PROFILE

Are you Simon J Harrison?   Register this Author

Register author
Simon J Harrison

Simon J Harrison

Publications by authors named "Simon J Harrison"

Are you Simon J Harrison?   Register this Author

59Publications

1262Reads

48Profile Views

First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study.

Authors:
Amit Khot Natalie Brajanovski Donald P Cameron Nadine Hein Kylee H Maclachlan Elaine Sanij John Lim John Soong Emma Link Piers Blombery Ella R Thompson Andrew Fellowes Karen E Sheppard Grant A McArthur Richard B Pearson Ross D Hannan Gretchen Poortinga Simon J Harrison

Cancer Discov 2019 Aug 15;9(8):1036-1049. Epub 2019 May 15.

Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

 Source
http://cancerdiscovery.aacrjournals.org/lookup/doi/10.1158/2
Publisher Site
http://dx.doi.org/10.1158/2159-8290.CD-18-1455DOI Listing
August 2019

Renal Impairment at Diagnosis in Myeloma: Patient Characteristics, Treatment, and Impact on Outcomes. Results From the Australia and New Zealand Myeloma and Related Diseases Registry.

Authors:
P Joy Ho Elizabeth M Moore Zoe K McQuilten Cameron Wellard Krystal Bergin Bradley Augustson Hilary Blacklock Simon J Harrison Noemi Horvath Tracy King Peter Mollee Hang Quach Christopher Reid Brian Rosengarten Patricia Walker Erica M Wood Andrew Spencer

Clin Lymphoma Myeloma Leuk 2019 Aug 16;19(8):e415-e424. Epub 2019 May 16.

Department of Haematology, Alfred Health-Monash University, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.clml.2019.05.010DOI Listing
August 2019

.

Authors:
Crystal Gao Christopher McCormack Carrie van der Weyden Michelle S Goh Belinda Campbell Robert Twigger Odette Buelens Simon J Harrison Christine Khoo Stephen Lade H Miles Prince

Blood 2019 Aug 29. Epub 2019 Aug 29.

Division of Cancer Medicine, Peter MacCallum Cancer Centre, Australia

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1182/blood.2019000765DOI Listing
August 2019

Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple Myeloma.

Authors:
Timothy A Brighton Amit Khot Simon J Harrison David Ghez Brendan M Weiss Andres Kirsch Hila Magen Mercedes Gironella Albert Oriol Matthew Streetly Britte Kranenburg Xiang Qin Rajesh Bandekar Peter Hu Mary Guilfoyle Ming Qi Sepideh Nemat Hartmut Goldschmidt

Clin Cancer Res 2019 Jul 19;25(13):3772-3775. Epub 2019 Mar 19.

University Hospital, Internal Medicine V and National Center for Tumor Diseases Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-3470DOI Listing
July 2019

The Use of Optimal Treatment for DLBCL Is Improving in All Age Groups and Is a Key Factor in Overall Survival, but Non-Clinical Factors Influence Treatment.

Authors:
Nicole Wong Doo Victoria M White Kara Martin Julie K Bassett H Miles Prince Simon J Harrison Michael Jefford Ingrid Winship Jeremy L Millar Roger L Milne John F Seymour Graham G Giles

Cancers (Basel) 2019 Jul 2;11(7). Epub 2019 Jul 2.

Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria 3004, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.3390/cancers11070928DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678990PMC
July 2019

Access, knowledge and experience with fluorodeoxyglucose positron emission tomography/computed tomography in infection management: a survey of Australia and New Zealand infectious diseases physicians and microbiologists.

Authors:
Abby P Douglas Karin A Thursky Leon J Worth Simon J Harrison Rodney J Hicks Monica A Slavin

Intern Med J 2019 05;49(5):615-621

Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

 Source
http://doi.wiley.com/10.1111/imj.14117
Publisher Site
http://dx.doi.org/10.1111/imj.14117DOI Listing
May 2019

The pharmacokinetics and pharmacodynamics of busulfan when combined with melphalan as conditioning in adult autologous stem cell transplant recipients.

Authors:
Abbey Willcox Eric Wong Christa Nath Brett Janson Simon J Harrison Rosemary Hoyt Ashish Bajel Peter Shaw David Ritchie Andrew Grigg

Ann Hematol 2018 Dec 26;97(12):2509-2518. Epub 2018 Jul 26.

Department of Clinical Haematology, Austin Hospital, Melbourne, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1007/s00277-018-3447-xDOI Listing
December 2018

Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma.

Authors:
Nicholas A Gherardin Liyen Loh Lorenztino Admojo Alexander J Davenport Kelden Richardson Amy Rogers Phillip K Darcy Misty R Jenkins H Miles Prince Simon J Harrison Hang Quach David P Fairlie Katherine Kedzierska James McCluskey Adam P Uldrich Paul J Neeson David S Ritchie Dale I Godfrey

Sci Rep 2018 03 7;8(1):4159. Epub 2018 Mar 7.

Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria, 3010, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1038/s41598-018-22130-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841305PMC
March 2018

Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma.

Authors:
Hang Quach Simon Benson Helen Haysom Anne-Marie Wilkes Nicole Zacher Merrole Cole-Sinclair Henry Miles Prince Peter Mollee Andrew Spencer Phoebe Joy Ho Simon J Harrison Cindy Lee Bradley Augustson James Daly

Intern Med J 2018 02;48(2):210-220

Australian and New Zealand Society of Blood Transfusion, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/imj.13707DOI Listing
February 2018

Promising efficacy and acceptable safety of venetoclax plus bortezomib and dexamethasone in relapsed/refractory MM.

Authors:
Philippe Moreau Asher Chanan-Khan Andrew W Roberts Amit B Agarwal Thierry Facon Shaji Kumar Cyrille Touzeau Elizabeth A Punnoose Jaclyn Cordero Wijith Munasinghe Jia Jia Ahmed Hamed Salem Kevin J Freise Joel D Leverson Sari Heitner Enschede Jeremy A Ross Paulo C Maciag Maria Verdugo Simon J Harrison

Blood 2017 11 28;130(22):2392-2400. Epub 2017 Aug 28.

Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; and.

View Article

Download full-text PDF

 Source
http://www.bloodjournal.org/lookup/doi/10.1182/blood-2017-06
Publisher Site
http://dx.doi.org/10.1182/blood-2017-06-788323DOI Listing
November 2017

Predicting Risk of Infection in Patients with Newly Diagnosed Multiple Myeloma: Utility of Immune Profiling.

Authors:
Benjamin W Teh Simon J Harrison Cody Charles Allison Monica A Slavin Tim Spelman Leon J Worth Karin A Thursky David Ritchie Marc Pellegrini

Front Immunol 2017 5;8:1247. Epub 2017 Oct 5.

Walter and Eliza Hall Institute, Parkville, VIC, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.3389/fimmu.2017.01247DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633726PMC
October 2017

Physical Activity Preferences for People Living With Multiple Myeloma: A Qualitative Study.

Authors:
Melinda Craike Kaye Hose Kerry S Courneya Simon J Harrison Patricia M Livingston

Cancer Nurs 2017 Sep/Oct;40(5):E1-E8

Author Affiliations: Institute of Sport, Exercise and Active Living (ISEAL), Victoria University, Melbourne, Australia (Dr Craike); Austin Health, Heidelberg, Australia (Ms Hose); Faculty of Physical Education and Recreation, University of Alberta, Edmonton, Canada (Dr Courneya); Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, and Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia (Dr Harrison); and Deakin University, Geelong, Australia, Faculty of Health (Dr Livingston).

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1097/NCC.0000000000000425DOI Listing
September 2017

Multiple myeloma of the spine.

Authors:
Arian Lasocki Frank Gaillard Simon J Harrison

Neuroradiol J 2017 Jun 20;30(3):259-268. Epub 2017 Apr 20.

5 Department of Cancer Medicine, Peter MacCallum Cancer Centre, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1177/1971400917699426DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480803PMC
June 2017

Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell population.

Authors:
Nadine Hein Donald P Cameron Katherine M Hannan Nhu-Y N Nguyen Chun Yew Fong Jirawas Sornkom Meaghan Wall Megan Pavy Carleen Cullinane Jeannine Diesch Jennifer R Devlin Amee J George Elaine Sanij Jaclyn Quin Gretchen Poortinga Inge Verbrugge Adele Baker Denis Drygin Simon J Harrison James D Rozario Jason A Powell Stuart M Pitson Johannes Zuber Ricky W Johnstone Mark A Dawson Mark A Guthridge Andrew Wei Grant A McArthur Richard B Pearson Ross D Hannan

Blood 2017 05 10;129(21):2882-2895. Epub 2017 Mar 10.

Australian Cancer Research Foundation Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1182/blood-2016-05-718171DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445570PMC
May 2017

Epidemiology of bloodstream infections in patients with myeloma receiving current era therapy.

Authors:
Benjamin W Teh Simon J Harrison Monica A Slavin Leon J Worth

Eur J Haematol 2017 Feb 10;98(2):149-153. Epub 2016 Oct 10.

Department of Infectious Diseases, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/ejh.12813DOI Listing
February 2017

Infection risk with immunomodulatory and proteasome inhibitor-based therapies across treatment phases for multiple myeloma: A systematic review and meta-analysis.

Authors:
Benjamin W Teh Simon J Harrison Leon J Worth Karin A Thursky Monica A Slavin

Eur J Cancer 2016 11 1;67:21-37. Epub 2016 Sep 1.

Department of Infectious Diseases, Peter MacCallum Cancer Centre, East Melbourne, Australia; Department of Medicine, University of Melbourne, Parkville, Australia; Victorian Infectious Diseases Service, Doherty Institute for Infection and Immunity, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.ejca.2016.07.025DOI Listing
November 2016

Outcome of the Stryker® Trident 'All-Poly' constraint acetabular insert: a district general hospital experience.

Authors:
Simon J Harrison Daniel J Leeder Timothy G McWilliams Robert W Metcalf Sameh A Sidhom

Hip Int 2015 Nov-Dec;25(6):557-62. Epub 2015 Jun 22.

Department of Trauma and Orthopaedics, Huddersfield Royal Infirmary, Huddersfield - UK.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.5301/hipint.5000263DOI Listing
October 2016

T-cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments.

Authors:
Edwin D Hawkins Delfim Duarte Olufolake Akinduro Reema A Khorshed Diana Passaro Malgorzata Nowicka Lenny Straszkowski Mark K Scott Steve Rothery Nicola Ruivo Katie Foster Michaela Waibel Ricky W Johnstone Simon J Harrison David A Westerman Hang Quach John Gribben Mark D Robinson Louise E Purton Dominique Bonnet Cristina Lo Celso

Nature 2016 10 17;538(7626):518-522. Epub 2016 Oct 17.

Department of Life Sciences, Sir Alexander Fleming Building, Imperial College London, London SW7 2AZ, UK.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1038/nature19801DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5164929PMC
October 2016

Phase I Clinical Trial of Marizomib (NPI-0052) in Patients with Advanced Malignancies Including Multiple Myeloma: Study NPI-0052-102 Final Results.

Authors:
Simon J Harrison Paul Mainwaring Timothy Price Michael J Millward Peeter Padrik Craig R Underhill Paul K Cannell Steven D Reich Mohit Trikha Andrew Spencer

Clin Cancer Res 2016 Sep 26;22(18):4559-66. Epub 2016 Apr 26.

The Alfred Hospital, Melbourne, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-2616DOI Listing
September 2016

Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patients.

Authors:
Nancy Levin Andrew Spencer Simon J Harrison Dharminder Chauhan Francis J Burrows Kenneth C Anderson Steven D Reich Paul G Richardson Mohit Trikha

Br J Haematol 2016 Sep 9;174(5):711-20. Epub 2016 May 9.

Triphase Accelerator, San Diego, CA, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/bjh.14113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084787PMC
September 2016

Spontaneous onset and transplant models of the Vk*MYC mouse show immunological sequelae comparable to human multiple myeloma.

Authors:
Rachel E Cooke Nicholas A Gherardin Simon J Harrison Hang Quach Dale I Godfrey Miles Prince Rachel Koldej David S Ritchie

J Transl Med 2016 09 6;14:259. Epub 2016 Sep 6.

ACRF Translational Research Laboratory, Royal Melbourne Hospital, Parkville, VIC, 3010, Australia.

View Article

Download full-text PDF

 Source
http://translational-medicine.biomedcentral.com/articles/10.
Publisher Site
http://dx.doi.org/10.1186/s12967-016-0994-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011922PMC
September 2016

Update and new approaches in the treatment of Castleman disease.

Authors:
Kah-Lok Chan Stephen Lade H Miles Prince Simon J Harrison

J Blood Med 2016 3;7:145-58. Epub 2016 Aug 3.

Department of Haematology; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.2147/JBM.S60514DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976903PMC
August 2016

Prevention of viral infections in patients with multiple myeloma: the role of antiviral prophylaxis and immunization.

Authors:
Benjamin W Teh Monica A Slavin Simon J Harrison Leon J Worth

Expert Rev Anti Infect Ther 2015 31;13(11):1325-36. Epub 2015 Aug 31.

a 1 Department of Infectious Diseases, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1586/14787210.2015.1083858DOI Listing
July 2016

Antiviral prophylaxis for varicella zoster virus infections in patients with myeloma in the era of novel therapies.

Authors:
Benjamin W Teh Simon J Harrison Leon J Worth Monica A Slavin

Leuk Lymphoma 2016 07 4;57(7):1719-22. Epub 2016 Jan 4.

a Department of Infectious Diseases , Peter MacCallum Cancer Centre , East Melbourne , Victoria , Australia ;

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.3109/10428194.2015.1106538DOI Listing
July 2016

Myeloma of the central nervous system - an ongoing conundrum!

Authors:
Simon J Harrison Andrew Spencer Hang Quach

Leuk Lymphoma 2016 07 21;57(7):1505-6. Epub 2016 Mar 21.

c St Vincent's Hospital , Melbourne , Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.3109/10428194.2016.1154961DOI Listing
July 2016

The Perspectives of Haematological Cancer Patients on Tissue Banking.

Authors:
Heidi Turon Amy Waller Tara Clinton-McHarg Allison Boyes Jennifer Fleming Paula Marlton Simon J Harrison Rob Sanson-Fisher

Oncol Ther 2016 3;4(1):91-102. Epub 2016 May 3.

School of Medicine and Public Health, Priority Research Centre for Health Behaviour, University of Newcastle, Newcastle, NSW Australia ; Hunter Medical Research Institute, Newcastle, NSW Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1007/s40487-016-0019-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315074PMC
May 2016

Global measures of peripheral blood-derived DNA methylation as a risk factor in the development of mature B-cell neoplasms.

Authors:
Nicole Wong Doo Enes Makalic JiHoon E Joo Claire M Vajdic Daniel F Schmidt Ee Ming Wong Chol-Hee Jung Gianluca Severi Daniel J Park Jessica Chung Laura Baglietto Henry Miles Prince John F Seymour Constantine Tam John L Hopper Dallas R English Roger L Milne Simon J Harrison Melissa C Southey Graham G Giles

Epigenomics 2016 Jan 18;8(1):55-66. Epub 2015 Dec 18.

Cancer Epidemiology Centre, Cancer Council Victoria, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.2217/epi.15.97DOI Listing
January 2016

Plasmacytoma of the testis in a patient with relapsed and refractory multiple myeloma: Case report and review of the literature.

Authors:
Munad Khan Nieroshan Rajarubendra Sarah Azer Alison Skene Simon J Harrison Belinda Campbell Nathan Lawrentschuk

Urol Ann 2015 Oct-Dec;7(4):530-3

Department of Surgery, University of Melbourne, Austin Hospital, Melbourne, Australia ; Olivia Newton-John Cancer Research Department, Austin Hospital, Melbourne, Australia ; Department of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.4103/0974-7796.164844DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660713PMC
December 2015

Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy.

Authors:
Benjamin W Teh Simon J Harrison Leon J Worth Tim Spelman Karin A Thursky Monica A Slavin

Br J Haematol 2015 Oct 24;171(1):100-8. Epub 2015 Jun 24.

Department of Infectious Diseases, Peter MacCallum Cancer Centre, East Melbourne, Vic., Australia.

View Article

Download full-text PDF

 Source
http://doi.wiley.com/10.1111/bjh.13532
Publisher Site
http://dx.doi.org/10.1111/bjh.13532DOI Listing
October 2015

Ceritinib in patients with advanced anaplastic lymphoma kinase-rearranged anaplastic large-cell lymphoma.

Authors:
Heike Richly Tae Min Kim Martin Schuler Dong-Wan Kim Simon J Harrison Alice T Shaw Anthony L Boral Alejandro Yovine Benjamin Solomon

Blood 2015 Sep;126(10):1257-8

Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1182/blood-2014-12-617779DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559938PMC
September 2015

Comment on "Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma".

Authors:
Simon J Harrison Hang Quach Andrew Spencer H Miles Prince

Haematologica 2015 Sep;100(9):e379

Peter MacCallum Cancer Centre, East Melbourne, Australia Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.3324/haematol.2015.128470DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800680PMC
September 2015

Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib: experience at an Australian Cancer Hospital.

Authors:
Benjamin W Teh Leon J Worth Simon J Harrison Karin A Thursky Monica A Slavin

Support Care Cancer 2015 Jul 10;23(7):1901-6. Epub 2014 Dec 10.

Department of Infectious Diseases, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia,

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1007/s00520-014-2550-3DOI Listing
July 2015

Myelosuppressive therapies significantly increase pro-inflammatory cytokines and directly cause bone loss.

Authors:
Julie M Quach Maria Askmyr Tanja Jovic Emma K Baker Nicole C Walsh Simon J Harrison Paul Neeson David Ritchie Peter R Ebeling Louise E Purton

J Bone Miner Res 2015 May;30(5):886-97

Stem Cell Regulation Unit, St Vincent's Institute of Medical Research, Fitzroy, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1002/jbmr.2415DOI Listing
May 2015

The addition of dexamethasone to bortezomib for patients with relapsed multiple myeloma improves outcome but ongoing maintenance therapy has minimal benefit.

Authors:
Simon J Harrison Hang Quach Emma Link Huaibao Feng Joanne Dean Michael Copeman Helgi Van De Velde Anthony Schwarer Bartrum Baker Andrew Spencer John Catalano Philip Campbell Bradley Augustson Ken Romeril Henry Miles Prince

Am J Hematol 2015 May 27;90(5):E86-91. Epub 2015 Feb 27.

Peter MacCallum Cancer Centre, East Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1002/ajh.23967DOI Listing
May 2015

The utility and limitations of (18)F-fluorodeoxyglucose positron emission tomography with computed tomography in patients with primary mediastinal B-cell lymphoma: single institution experience and literature review.

Authors:
Chan Y Cheah Michael S Hofman John F Seymour David S Ritchie Michael Dickinson Andrew Wirth H Miles Prince Max Wolf Elchanan H Januszcewicz Dennis A Carney Kirsten E Herbert Simon J Harrison Kate L Burbury Constantine S Tam

Leuk Lymphoma 2015 Jan 16;56(1):49-56. Epub 2014 Jun 16.

Department of Haematology, Peter MacCallum Cancer Centre , East Melbourne, Victoria , Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.3109/10428194.2014.910656DOI Listing
January 2015

Invasive fungal infections in patients with multiple myeloma: a multi-center study in the era of novel myeloma therapies.

Authors:
Benjamin W Teh Jasmine C Teng Karin Urbancic Andrew Grigg Simon J Harrison Leon J Worth Monica A Slavin Karin A Thursky

Haematologica 2015 Jan 10;100(1):e28-31. Epub 2014 Oct 10.

Department of Infectious Diseases, Peter MacCallum Cancer Centre, East Melbourne Department of Medicine, University of Melbourne Victorian Infectious Diseases Service, Peter Doherty Institute for Infection and Immunity, Parkville, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.3324/haematol.2014.114025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281332PMC
January 2015

The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma.

Authors:
Andrew Spencer Sung-Soo Yoon Simon J Harrison Shannon R Morris Deborah A Smith Richard A Brigandi Jennifer Gauvin Rakesh Kumar Joanna B Opalinska Christine Chen

Blood 2014 Oct 29;124(14):2190-5. Epub 2014 Jul 29.

Princess Margaret Hospital, Toronto, ON, Canada.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1182/blood-2014-03-559963DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229853PMC
October 2014

The choice of multiple myeloma induction therapy affects the frequency and severity of oral mucositis after melphalan-based autologous stem cell transplantation.

Authors:
Shaun Fleming Simon J Harrison Piers Blombery Trish Joyce Kerrie Stokes John F Seymour H Miles Prince David Ritchie

Clin Lymphoma Myeloma Leuk 2014 Aug 15;14(4):291-6. Epub 2014 Feb 15.

The Royal Melbourne Hospital, Victoria, Australia; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; University of Melbourne, Victoria, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.clml.2014.02.001DOI Listing
August 2014

Limited clinical benefit for surveillance PET-CT scanning in patients with histologically transformed lymphoma in complete metabolic remission following primary therapy.

Authors:
Chan Y Cheah Michael Dickinson Michael S Hofman Anupkumar George David S Ritchie H Miles Prince David Westerman Simon J Harrison Kate Burbury Max Wolf Henry Januszewicz Kirsten E Herbert Dennis A Carney Constantine Tam John F Seymour

Ann Hematol 2014 Jul 5;93(7):1193-200. Epub 2014 Mar 5.

Department of Haematology, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett St, East Melbourne, 8006, Victoria, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1007/s00277-014-2040-1DOI Listing
July 2014

Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant.

Authors:
Simon J Harrison Andy K Hsu Paul Neeson Anas Younes Anna Sureda Andreas Engert H Miles Prince Martha Li Paula Savage Roberto Bugarini Denise Williams Margaret Squier David S Ritchie

Leuk Lymphoma 2014 May 5;55(5):1053-60. Epub 2013 Aug 5.

Sir Peter MacCallum Department of Oncology, University of Melbourne , Parkville, Victoria , Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.3109/10428194.2013.820287DOI Listing
May 2014

Myeloma and pregnancy: strange bedfellows?

Authors:
Amit S Khot H Miles Prince Simon J Harrison John F Seymour

Leuk Lymphoma 2014 Apr 9;55(4):966-8. Epub 2013 Sep 9.

Department of Haematology, Peter MacCallum Cancer Centre , Melbourne , Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.3109/10428194.2013.837163DOI Listing
April 2014

Changing treatment paradigms for patients with plasma cell myeloma: impact upon immune determinants of infection.

Authors:
Benjamin W Teh Simon J Harrison Marc Pellegrini Karin A Thursky Leon J Worth Monica A Slavin

Blood Rev 2014 Mar 10;28(2):75-86. Epub 2014 Feb 10.

Department of Infectious Diseases, Peter MacCallum Cancer Centre, East Melbourne, Australia; Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.blre.2014.01.004DOI Listing
March 2014

A cohort study on the incidence and outcome of pulmonary embolism in trauma and orthopedic patients.

Authors:
Suribabu Gudipati Evangelos M Fragkakis Vincenzo Ciriello Simon J Harrison Petros Z Stavrou Nikolaos K Kanakaris Robert M West Peter V Giannoudis

BMC Med 2014 Mar 4;12:39. Epub 2014 Mar 4.

Academic Department of Trauma and Orthopaedics, School of Medicine, University of Leeds, Leeds General Infirmary, Clarendon Wing Level A, Great George Street, LS1 3EX Leeds, West Yorkshire, UK.

View Article

Download full-text PDF

 Source
http://bmcmedicine.biomedcentral.com/articles/10.1186/1741-7
Publisher Site
http://dx.doi.org/10.1186/1741-7015-12-39DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996019PMC
March 2014

Low uptake of upfront autologous transplantation for myeloma in a jurisdiction with universal health care coverage: a population-based patterns of care study in Australia.

Authors:
Nicole Wong Doo Michael Coory Victoria White Simon J Harrison H Miles Prince Jeremy L Millar Margaret Dimech Graham G Giles

Clin Lymphoma Myeloma Leuk 2014 Feb 1;14(1):61-7. Epub 2013 Oct 1.

Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia; Cancer Strategy and Development, Department of Health, Melbourne, Victoria, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

 Source
https://linkinghub.elsevier.com/retrieve/pii/S21522650130043
Publisher Site
http://dx.doi.org/10.1016/j.clml.2013.09.011DOI Listing
February 2014

Bortezomib with high dose melphalan conditioning for autologous transplant is safe and effective in patients with heavily pretreated and high risk multiple myeloma.

Authors:
Nicole Wong Doo Philip A Thompson H Miles Prince John F Seymour David Ritchie Kerrie Stokes Kate Burbury Max Wolf Trish Joyce Simon J Harrison

Leuk Lymphoma 2013 Jul 14;54(7):1465-72. Epub 2012 Dec 14.

Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.

View Article

Download full-text PDF

 Source
https://www.tandfonline.com/doi/full/10.3109/10428194.2012.7
Publisher Site
http://dx.doi.org/10.3109/10428194.2012.746682DOI Listing
July 2013

Perceived benefits and barriers to exercise for recently treated patients with multiple myeloma: a qualitative study.

Authors:
Melinda J Craike Kaye Hose Kerry S Courneya Simon J Harrison Patricia M Livingston

BMC Cancer 2013 Jul 1;13:319. Epub 2013 Jul 1.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1186/1471-2407-13-319DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702408PMC
July 2013

Histone deacetylase inhibitors reduce glycoprotein VI expression and platelet responses to collagen related peptide.

Authors:
Mark J Bishton Elizabeth E Gardiner Simon J Harrison H Miles Prince Ricky W Johnstone

Thromb Res 2013 Jun 2;131(6):514-20. Epub 2013 May 2.

Cancer Research Division, The Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne 3002, Victoria, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.thromres.2013.02.013DOI Listing
June 2013

Emergence of central nervous system myeloma in the era of novel agents.

Authors:
Shane A Gangatharan Dennis A Carney H Miles Prince Max M Wolf E Henry Januszewicz David S Ritchie Simon J Harrison

Hematol Oncol 2012 Dec 5;30(4):170-4. Epub 2011 Dec 5.

Department of Haematology, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne 3002, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1002/hon.1021DOI Listing
December 2012

A focus on the preclinical development and clinical status of the histone deacetylase inhibitor, romidepsin (depsipeptide, Istodax(®)).

Authors:
Simon J Harrison Mark Bishton Susan E Bates Steven Grant Richard L Piekarz Ricky W Johnstone Yun Dai Becki Lee Maria E Araujo H Miles Prince

Epigenomics 2012 Oct;4(5):571-89

Haematology Service, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.2217/epi.12.52DOI Listing
October 2012

Panobinostat in patients with relapsed/refractory Hodgkin's lymphoma after autologous stem-cell transplantation: results of a phase II study.

Authors:
Anas Younes Anna Sureda Dina Ben-Yehuda Pier Luigi Zinzani Tee-Chuan Ong H Miles Prince Simon J Harrison Mark Kirschbaum Patrick Johnston Jennifer Gallagher Christophe Le Corre Angela Shen Andreas Engert

J Clin Oncol 2012 Jun 30;30(18):2197-203. Epub 2012 Apr 30.

MD Anderson Cancer Center, 1515 Holcombe Blvd, Unite 429, Houston, TX 77030, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1200/JCO.2011.38.1350DOI Listing
June 2012

M(yeloma)IXing up T maintenance.

Authors:
Simon J Harrison Amit Khot

Blood 2012 Jan;119(1):1-2

Peter MacCallum Cancer Centre, University of Melbourne.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1182/blood-2011-11-388181DOI Listing
January 2012

A high rate of durable responses with romidepsin, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma.

Authors:
Simon J Harrison Hang Quach Emma Link John F Seymour David S Ritchie Sam Ruell Joanne Dean Henry Januszewicz Ricky Johnstone Paul Neeson Michael Dickinson Jean Nichols H Miles Prince

Blood 2011 Dec 12;118(24):6274-83. Epub 2011 Sep 12.

Haematology Department, Peter MacCallum Cancer Centre, East Melbourne, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1182/blood-2011-03-339879DOI Listing
December 2011

To validate: is it so simple?

Authors:
Melisa Darby Simon J Harrison

Transfus Apher Sci 2011 Oct 27;45(2):209-11. Epub 2011 Aug 27.

Apheresis Unit, Peter MacCallum Cancer Centre, East Melbourne, Australia.

View Article

Download full-text PDF

 Source
https://linkinghub.elsevier.com/retrieve/pii/S14730502110012
Publisher Site
http://dx.doi.org/10.1016/j.transci.2011.07.004DOI Listing
October 2011

Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor-induced thrombocytopenia.

Authors:
Mark J Bishton Simon J Harrison Benjamin P Martin Nicole McLaughlin Chloé James Emma C Josefsson Katya J Henley Benjamin T Kile H Miles Prince Ricky W Johnstone

Blood 2011 Mar 3;117(13):3658-68. Epub 2011 Feb 3.

Cancer Therapeutics Program, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, VIC 3002, Australia

View Article

Download full-text PDF

 Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2010-11-31
Publisher Site
http://dx.doi.org/10.1182/blood-2010-11-318055DOI Listing
March 2011

The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy.

Authors:
Andy K Hsu Hang Quach Tsin Tai H Miles Prince Simon J Harrison Joseph A Trapani Mark J Smyth Paul Neeson David S Ritchie

Blood 2011 Feb 26;117(5):1605-13. Epub 2010 Oct 26.

Hematology Immunology Translational Research Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1182/blood-2010-04-278432DOI Listing
February 2011

Bortezomib, cyclophosphamide, and dexamethasone: highly effective for rapid reversal of myeloma-associated hyperammonemic encephalopathy.

Authors:
Rebecca Howman Arti Thakerer Matthew Pitman Nik Ding Philip A Thompson Amit Khot Simon J Harrison

Leuk Lymphoma 2010 Dec 7;51(12):2299-302. Epub 2010 Oct 7.

View Article

Download full-text PDF

 Source
http://www.tandfonline.com/doi/full/10.3109/10428194.2010.51
Publisher Site
http://dx.doi.org/10.3109/10428194.2010.518654DOI Listing
December 2010

Clinical studies of histone deacetylase inhibitors.

Authors:
H Miles Prince Mark J Bishton Simon J Harrison

Clin Cancer Res 2009 Jun 9;15(12):3958-69. Epub 2009 Jun 9.

Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Melbourne, Australia and University of Melbourne, Parkville, Victoria, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-2785DOI Listing
June 2009

Enumeration of blood dendritic cells in patients with multiple myeloma at presentation and through therapy.

Authors:
Simon J Harrison Ian M Franklin John D M Campbell

Leuk Lymphoma 2008 Dec;49(12):2272-83

Haematology Service, Peter MacCallum Cancer Centre, Melbourne, Australia.

View Article

Download full-text PDF

 Source
http://www.tandfonline.com/doi/full/10.1080/1042819080246472
Publisher Site
http://dx.doi.org/10.1080/10428190802464729DOI Listing
December 2008

Immunotherapy of multiple myeloma: the start of a long and tortuous journey.

Authors:
Simon J Harrison Gordon Cook Robert J B Nibbs H Miles Prince

Expert Rev Anticancer Ther 2006 Dec;6(12):1769-85

DHMO, Peter MacCallum Cancer Centre and Locked Bag 1, A'becket Street, Melbourne, Victoria 8006, Australia.

View Article

Download full-text PDF

 Source
http://www.tandfonline.com/doi/full/10.1586/14737140.6.12.17
Publisher Site
http://dx.doi.org/10.1586/14737140.6.12.1769DOI Listing
December 2006